Skip to main content
. Author manuscript; available in PMC: 2023 Jul 21.
Published in final edited form as: J Alzheimers Dis. 2022;87(3):1229–1238. doi: 10.3233/JAD-210391

Table 1.

Descriptive statistics for entire sample and by amyloid β (Aβ) positivity determined from Aβ positron emission tomography. Aβ positivity was by k-means clustering (SUVR = 1.34).

Characteristic Entire Sample (n = 345) Aβ Negative (n = 317) Aβ Positive (n = 28) p-value
Age, mean (SD), yr. 64.13 (3.32) 64.06 (3.33) 64.88 (3.16) 0.20
Women, No. (%) 248 (71.88) 227 (71.61) 21 (75.00) 0.87
Education, mean (SD), yr. 10.55 (3.96) 10.45 (3.97) 11.71 (3.68) 0.092
Ethnicity, No. (%)
 Dominican 295 (85.51) 273 (86.12) 22 (78.57) 0.42
 Other Caribbean Hispanic 21 (6.09) 18 (5.68) 3 (10.71)
 South American 18 (5.22) 16 (5.05) 2 (7.14)
 Unspecified Hispanic 7 (2.03) 6 (1.89) 1 (3.57)
 Central American 4 (1.16) 4 (1.26) 0 (0)
APOE-ε4, No. (%) 123 (35.65) 102 (32.18) 21 (75.00) <0.0001
Cystatin C, mean (SD), mg/L 0.97 (0.43) 0.98 (0.44) 0.94 (0.15) 0.78
SRT: Total Recall, mean (SD), words 38.94 (8.82) 39.00 (8.69) 38.33 (10.40) 0.75
Plasma Aβ40, mean (SD), pg/mL 222.98 (61.15) 223.05 (61.14) 222.18 (62.33) 0.94
Plasma Aβ42, mean (SD), pg/mL 14.27 (3.98) 14.39 (3.98) 12.91 (3.77) 0.057
Aβ42/Aβ40 ratio, mean (SD) 0.065 (0.013) 0.065 (0.013) 0.058 (0.009) 0.0005